338 related articles for article (PubMed ID: 28932572)
1. Chronic lung allograft dysfunction phenotypes and treatment.
Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
[TBL] [Abstract][Full Text] [Related]
2. Restrictive chronic lung allograft dysfunction: Where are we now?
Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Van Raemdonck DE; Dupont LJ; Vanaudenaerde BM; Verleden G; Vos R
J Heart Lung Transplant; 2015 May; 34(5):625-30. PubMed ID: 25577564
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
4. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
5. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
7. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
Sato M
Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
[TBL] [Abstract][Full Text] [Related]
9. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
[TBL] [Abstract][Full Text] [Related]
11. Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).
Brun AL; Chabi ML; Picard C; Mellot F; Grenier PA
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33946544
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
13. Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study.
Verleden SE; Todd JL; Sato M; Palmer SM; Martinu T; Pavlisko EN; Vos R; Neyrinck A; Van Raemdonck D; Saito T; Oishi H; Keshavjee S; Greer M; Warnecke G; Gottlieb J; Haverich A
Am J Transplant; 2015 Aug; 15(8):2223-30. PubMed ID: 25940517
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Dubbeldam A; De Wever W; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Benden C; Vos R
J Heart Lung Transplant; 2016 Sep; 35(9):1078-84. PubMed ID: 27212563
[TBL] [Abstract][Full Text] [Related]
15. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
16. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
17. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study.
Davidsen JR; Laursen CB; Højlund M; Lund TK; Jeschke KN; Iversen M; Kalhauge A; Bendstrup E; Carlsen J; Perch M; Henriksen DP; Schultz HHL
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33807615
[TBL] [Abstract][Full Text] [Related]
18. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
[TBL] [Abstract][Full Text] [Related]
19. Detection, classification, and management of rejection after lung transplantation.
Parulekar AD; Kao CC
J Thorac Dis; 2019 Sep; 11(Suppl 14):S1732-S1739. PubMed ID: 31632750
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
